Capital Analysts, LLC: SPEM position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Capital Analysts, LLC on SPEM, newest first. How the timeline and the estimate are built.
Capital Analysts, LLC held 347,144 SPEM shares at 2026-09-30 per its 13F-HR filed 2026-11-13.
the latest 13F is the newest step
- period ended2026-09-3013F 347,144 sharesChange vs previous 13F -8,038 shares
0.39% of the 13F portfolio, value $17,968,160.
13F-HR 0001624758-26-000047 filed by Capital Analysts, LLC
Accepted , ingested - period ended2026-06-3013F/A 355,182 sharesChange vs previous 13F +8,799 shares
0.42% of the 13F portfolio, value $18,391,326.
13F-HR/A 0001624758-26-000016 filed by Capital Analysts, LLC
Accepted , ingested - period ended2026-03-3113F/A 346,383 sharesChange vs previous 13F +11,753 shares
0.43% of the 13F portfolio, value $16,252,245.
13F-HR/A 0001624758-26-000018 filed by Capital Analysts, LLC
Accepted , ingested - period ended2025-12-3113F/A 334,630 sharesChange vs previous 13F +12,180 shares
0.43% of the 13F portfolio, value $15,664,066.
13F-HR/A 0001624758-26-000020 filed by Capital Analysts, LLC
Accepted , ingested - period ended2025-09-3013F/A 322,450 sharesChange vs previous 13F +130,782 shares
0.44% of the 13F portfolio, value $15,093,904.
13F-HR/A 0001624758-26-000022 filed by Capital Analysts, LLC
Accepted , ingested - period ended2025-06-3013F/A 191,668 sharesChange vs previous 13F +40,674 shares
0.27% of the 13F portfolio, value $8,191,896.
13F-HR/A 0001624758-26-000024 filed by Capital Analysts, LLC
Accepted , ingested - period ended2025-03-3113F/A 150,994 sharesChange vs previous 13F +19,444 shares
0.22% of the 13F portfolio, value $5,944,633.
13F-HR/A 0001624758-26-000026 filed by Capital Analysts, LLC
Accepted , ingested - period ended2024-12-3113F/A 131,550 sharesChange vs previous 13F not available
0.2% of the 13F portfolio, value $5,047,587.
13F-HR/A 0001624758-26-000028 filed by Capital Analysts, LLC
Accepted , ingested